Strain Information | |
---|---|
Image | |
BRC No. | RBRC05258 |
Type | Transgene |
Species | Mus musculus |
Strain name | B6.B6D2-Tg(CAG-Fad24)L4-3HMaim |
Former Common name | B6-Fad24 Tg#L4-3H |
H-2 Haplotype | |
ES Cell line | |
Background strain | |
Appearance | |
Strain development | Developed by Masayoshi Imagawa, Department of Molecular Biology, Graduate School of Pharmaceutical Sciences, Nagoya City University in 2006. |
Strain description | Transgenic mice having a mouse fad24 under control of the CAG promoter. |
Colony maintenance | Carrier X Noncarrier [C57BL/6J(Crlj)] |
References | Fad24 causes hyperplasia in adipose tissue and improves glucose metabolism. Johmura Y, Watanabe K, Kishimoto K, Ueda T, Shimada S, Osada S, Nishizuka M, Imagawa M Biol. Pharm. Bull., 32, 1656-1664 (2009). 19801824 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Fad24 | mouse Factor for adipocyte differentiation 24 | UN | Fad24 | CAG promoter (CMV-IE enhancer, chicken beta-actin promoter, rabbit beta-globin genomic DNA) |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | more 1 phenotypes |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | mouse Factor for adipocyte differentiation 24 (fad24) gene cDNA chicken Beta-actin promoter, rabbit Beta-globin polyA, CMV CMV-IE enhancer |
Research application | Diabetes and Obesity Research covid19_progression |
Specific Term and Conditions | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Biol Pharm Bull. 2009 32(10):1656-64. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from Dr.Makoto Nishizuka (nishizuka@hirosaki-u.ac.jp) using the Approval Form. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. |
Depositor | Masayoshi Imagawa (Nagoya City University) |
Strain Status | Frozen embryos Frozen sperm |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved sperm (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |